Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury

doi:10.4252/wjsc.v16.i7.742

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2089)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

HTML

1158

Figures (1-6)

131

Tables (1-3)

145

Sum=1480

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

176

Download

193

Sum=369

Publishing Process of This Article

Item

Count

Browse

Download

130

Sum=180

Jul 26, 2024 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Jul 26, 2024; 16(7): 742-759
Published online Jul 26, 2024. doi: 10.4252/wjsc.v16.i7.742

Full Size Figure Download Figure

Figure 3 Properties of Wharton’s jelly mesenchymal stem cells. Wharton’s jelly mesenchymal stem cells possess trilineage differentiation potential, making them multipotent. They are immune-suppressive, immunoprivileged, and non-tumorigenic, ideal for allogeneic and xenogeneic transplantation due to their favorable properties (created with BioRender.com). IL: Interleukin; MHC: Major histocompatibility class; TGF: Transforming growth factor.

Citation: Sharma P, Maurya DK. Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury. World J Stem Cells 2024; 16(7): 742-759
URL: https://www.wjgnet.com/1948-0210/full/v16/i7/742.htm
DOI: https://dx.doi.org/10.4252/wjsc.v16.i7.742